Retraction: A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons
- PMID: 23118563
- PMCID: PMC3484524
- DOI: 10.4196/kjpp.2012.16.5.367
Retraction: A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons
Retraction of
-
A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons.Korean J Physiol Pharmacol. 2012 Aug;16(4):237-41. doi: 10.4196/kjpp.2012.16.4.237. Epub 2012 Aug 10. Korean J Physiol Pharmacol. 2012. Retraction in: Korean J Physiol Pharmacol. 2012 Oct;16(5):367. doi: 10.4196/kjpp.2012.16.5.367. PMID: 22915988 Free PMC article. Retracted.
References
-
- Chung G, Kim TH, Shin H, Chae E, Yi H, Moon H, Kim HJ, Kim JS, Jung SJ, Oh SB. A novel carbamoyloxy arylalkanoyl arylpiperazine compound (SKL-NP) inhibits hyperpolarization-activated cyclic nucleotide-gated (HCN) channel currents in rat dorsal root ganglion neurons. Korean J Physiol Pharmacol. 2012;16:237–241. - PMC - PubMed